摘要
目的 研究参芪扶正射液对慢性肺源性心脏病急性发作期的治疗作用。方法 采用随机原则将 6 0例慢性肺源性心脏病急性发作期患者分为 2组 (各 30例 ) ,其中治疗组加用参芪扶正注射液 ,每天静滴 2 5 0ml,14天为 1疗程 ,对照组和治疗组均行一般慢性肺源性心脏病急性发作期的内科治疗 ,全部病例均在入院时及治疗 14天后查血气、胸片、血常规。结果 治疗组及对照组治疗前血氧分压和血二氧化碳分压比较无显著性差异 (P >0 0 5 ) ,治疗组及对照组治疗后与治疗前血氧分压和血二氧化碳分压比较有显著性差异 (P <0 0 1) ,治疗组与对照组治疗后血氧分压和血二氧化碳分压比较有显著性差异 (P <0 0 1) ,治疗组与对照组治疗后症状改善情况比较也有显著性差异 (P <0 0 5 )。结论 加用参芪扶正注射液可明显提高慢性肺源性心脏病急性发作期患者的血氧分压 ,降低二氧化碳分压 。
Objective To study the therapeutic effect of Shengqi Fuzheng Injuction in the treatment to acute attack of chronic cor pulmonale. Methods 60 patients with acute attack of chronic cor pulmonale were randomly divided into two groups:therapy group and control group,30 patients in each.Normal treatment was given to the two groups while introvenous drip of Shenqi Fuzheng Injection was added to the therapy group,250ml per day,14 days as a course.Blood gas analysis,chest X ray and blood routine were given to all the patients when admitted and after the treatment for 14 days. Results Before treatment,there was no significant difference of PaO2 and PaCO2 between the two groups( P >0 05),but after treatment,there existed a great difference of PaO2 between the two groups( P <0 01).The therapy group showed a greater symptom improvement than the control group after being treated. Conclusion Shenqi Fuzheng Injection added to the normal treatment may greatly increase the level of PaO2 of the patients with acute attack of chronic cor pulmonale and decrease the level of PaCO2,and can improve the symptoms.
出处
《西南军医》
2004年第3期5-6,8,共3页
Journal of Military Surgeon in Southwest China
关键词
肺心病
参芪扶正注射液
血气分析
cor pulmonale Shengqi Fuzheng Injection blood gas analysis
